Is Pancragen FDA approved?
No. This profile records Pancragen as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
Healing CATEGORY
Pancragen
THE PANCREAS PROTECTOR
PE-6 (Glu-Asp-Pro)
Pancragen is a synthetic tetrapeptide bioregulator that supports pancreatic health. It works by modulating gene expression in pancreatic cells to restore beta-cell function, enhance insulin secretion, and reduce inflammation. This makes it potentially valuable for pre-diabetes, metabolic syndrome, and maintaining healthy blood sugar as you age.
Pancragen
Pancragen
Pancragen
Pancragen Evidence Snapshot
How these guides are reviewed
REGULATORY STATUS
Not FDA approved · research use only
DOSING GUIDANCE
Reviewed by our clinical team
LINKED EVIDENCE
1 research sources
CONTENT UPDATED
Aug 28, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
Quick Answers About Pancragen
What dose does The Peptide App Clinical Team recommend for Pancragen?
Dose: 2 mg daily (oral or subcutaneous).
MORE CONTEXT ›
Schedule: daily. Cycle: 10 days on, repeat every 4-6 months. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
What research supports this Pancragen guide?
This guide links to 1 curated or current research sources.
MORE CONTEXT ›
Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Studied Effects & Mechanisms
Gene Activation
Promotes chromatin remodeling in pancreatic cells
Beta-Cell Regeneration
Supports islet cell regeneration and function
Insulin Secretion
Enhances insulin release in response to glucose
Anti-Inflammatory
Reduces inflammatory mediators in pancreatic tissue
Those with pre-diabetes or metabolic syndrome
People wanting to support healthy blood sugar
Anyone with a family history of diabetes
Those recovering from pancreatitis
Pancragen Research
Live research temporarily unavailableThe live research feed did not return papers for this page. The curated references below remain available for crawlable source context.